Protocol Builder

Aggressive multi-modal weight loss protocol combining injectable GLP-1 receptor agonist (Semaglutide) with lipotropic injections, low-dose naltrexone for craving reduction, and B12 for energy support. For patients requiring maximum intervention.

BPC-157 focused protocol for gastrointestinal healing, leaky gut, and inflammatory bowel support. BPC-157 (Body Protection Compound) promotes mucosal healing, angiogenesis, and anti-inflammatory pathways in the GI tract.

Topical erectile dysfunction protocol using compounded Scream Cream (Sildenafil/Arginine/Papaverine/Testosterone). Applied directly to the penile shaft for rapid local absorption. Suitable as first-line or adjunct therapy for mild-to-moderate ED.

Multi-modal protocol addressing female sexual dysfunction including hypoactive sexual desire disorder (HSDD) and arousal difficulties. Combines topical arousal cream with oxytocin for bonding and desire enhancement.

Testosterone replacement combined with low-dose nandrolone decanoate for patients with concurrent joint pain, osteoarthritis, or connective tissue issues. Nandrolone provides anabolic joint-protective effects and collagen synthesis stimulation.

Combination protocol using Low Dose Naltrexone for appetite regulation and craving reduction alongside GLP-1 therapy. LDN at higher doses (up to 4.5mg) can reduce food cravings and support metabolic health.

Protocol targeting sleep quality and stress resilience through hormonal and peptide support. Progesterone provides GABAergic calming effects, while sermorelin enhances deep sleep GH pulses.

Intravenous or injectable glutathione protocol for detoxification, immune support, and skin health. Glutathione is the body's master antioxidant, critical for Phase II liver detoxification and cellular protection.

Advanced dual-pathway weight management using both GLP-1 (Semaglutide) and GIP/GLP-1 (Tirzepatide) receptor agonists in sequence or rotation. For patients who have plateaued on single-agent therapy.

Classic testosterone replacement therapy for hypogonadal males. Includes testosterone cypionate as the primary androgen, anastrozole for estrogen management, and HCG to maintain testicular function and fertility.

Advanced peptide combination for accelerated tissue repair, injury recovery, and anti-inflammatory support. Combines BPC-157 for tissue healing with TB-500 (Thymosin Beta-4) for cellular migration and wound repair.

Injectable lipotropic protocol combining MIC (Methionine, Inositol, Choline) with B12 for enhanced fat metabolism, energy production, and liver support. Popular adjunct to diet and exercise programs.

First-line erectile dysfunction protocol using oral PDE5 inhibitors. Tadalafil provides a longer duration of action (up to 36 hours) for on-demand or daily use, with sildenafil as an alternative for faster onset.

Combined thyroid and adrenal support for patients with concurrent hypothyroidism and adrenal fatigue. Addresses the thyroid-adrenal axis connection, as adrenal dysfunction can impair thyroid hormone conversion.

Low Dose Naltrexone protocol for autoimmune and chronic inflammatory conditions. LDN modulates the immune system by temporarily blocking opioid receptors, leading to upregulation of endorphins and enkephalins with anti-inflammatory effects.

Post-cycle therapy protocol for patients transitioning off exogenous testosterone or anabolic therapy. Designed to restore endogenous HPG axis function, prevent estrogen rebound, and maintain gains during recovery.

Full-spectrum male optimization protocol combining TRT, estrogen management, growth hormone secretagogue, and metabolic support. For patients seeking comprehensive hormonal, body composition, and performance optimization.

Early intervention protocol for perimenopausal women experiencing irregular cycles, mood changes, and early vasomotor symptoms. Focuses on progesterone support and gentle estrogen supplementation before full HRT is needed.

Growth hormone secretagogue protocol using sermorelin for natural GH pulse stimulation. Supports anti-aging, body composition, sleep quality, and recovery without exogenous GH administration.

Testosterone replacement combined with PDE5 inhibitor support for patients with concurrent erectile dysfunction. Addresses both hormonal and vascular components of sexual health.

Comprehensive hormone replacement for perimenopausal and postmenopausal women. Combines bioidentical estrogen and progesterone to manage vasomotor symptoms, bone health, and quality of life.

Female hormone replacement with added low-dose testosterone and oxytocin for patients with hypoactive sexual desire disorder (HSDD) alongside menopausal symptoms.

GLP-1 receptor agonist-based weight management protocol. Semaglutide provides appetite suppression and metabolic benefits, supported by B12 for energy and optional naltrexone for craving reduction.

Dual GIP/GLP-1 receptor agonist protocol using tirzepatide for enhanced weight loss. Tirzepatide offers superior weight reduction compared to single-agonist approaches.

Comprehensive thyroid support protocol combining T4 and T3 for patients with hypothyroidism not fully optimized on T4 monotherapy. Addresses both conversion issues and direct T3 supplementation.

Peptide-based protocol for tissue repair, recovery, and anti-inflammatory support. BPC-157 promotes gut and tissue healing while sermorelin supports growth hormone release for recovery.

Evidence-based longevity protocol combining rapamycin (mTOR inhibition), NAD+ precursors, and antioxidant support for cellular health and healthy aging.

Multi-modal approach to androgenetic alopecia combining DHT reduction, topical growth stimulation, and nutritional support for hair follicle health.

Protocol designed to optimize male fertility while maintaining or restoring testosterone levels. Focuses on gonadotropin stimulation and avoiding testosterone suppression of spermatogenesis.

Comprehensive adrenal support protocol for patients with adrenal fatigue or HPA axis dysfunction. Combines DHEA, pregnenolone, and B-vitamin support for cortisol rhythm restoration.

BPC-157 is a pentadecapeptide with a wide range of healing and regenerative properties. This protocol is designed for providers to use BPC-157 to accelerate the healing of various tissues, including muscle, tendon, ligament, and bone, as well as to improve gut health and address inflammatory conditions.

This protocol combines four powerful peptides—BPC-157, GHK-Cu, KPV, and TB-500—to provide a multi-faceted approach to healing and regeneration. It is designed for comprehensive tissue repair, potent anti-inflammatory effects, and enhanced skin and connective tissue health. The synergistic action of these peptides makes it a robust option for patients with complex injuries or those seeking advanced recovery and rejuvenation.

This advanced protocol combines the synergistic effects of BPC-157, TB-500, and GHK-Cu to provide comprehensive support for tissue regeneration. BPC-157 and TB-500 work together to accelerate the healing of muscles, tendons, and ligaments, while GHK-Cu promotes collagen synthesis and skin repair. This powerful combination is designed for providers seeking to offer patients a multi-faceted approach to recovery and anti-aging.

This protocol combines the synergistic effects of BPC-157, KPV, and TB500 to offer a powerful solution for tissue repair, gut healing, and inflammation reduction. BPC-157 and TB500 work together to accelerate the healing of soft tissues, while KPV provides potent anti-inflammatory action, making this combination ideal for complex injuries and chronic inflammatory conditions.

This protocol combines BPC-157 and TB-500 to create a powerful synergistic effect for healing. BPC-157 offers potent localized tissue repair and anti-inflammatory benefits, while TB-500 promotes systemic healing, cell migration, and angiogenesis. This dual-action approach is prescribed for comprehensive and accelerated recovery from various musculoskeletal injuries.

This protocol combines CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue and ghrelin receptor agonist. Together, they synergistically increase the pulsatile release of growth hormone from the pituitary gland. This dual-action approach provides a sustained elevation in GH and IGF-1 levels, making it a powerful tool for providers seeking to optimize body composition, enhance recovery, and address age-related growth hormone decline in patients.

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide that plays a crucial role in the regulation of deep, restorative sleep. This protocol is designed for providers to use with patients experiencing insomnia, disrupted sleep architecture, or poor sleep quality, aiming to normalize sleep cycles and improve overall sleep efficiency without the side effects of traditional hypnotics.

This protocol combines three peptides—DSIP, BPC-157, and CJC-1295—to create a powerful synergistic blend for sleep, tissue repair, and growth hormone optimization. DSIP (Delta Sleep-Inducing Peptide) helps regulate deep sleep cycles, BPC-157 accelerates tissue healing and reduces inflammation, and CJC-1295 stimulates the body's natural production of growth hormone. It is prescribed for patients seeking comprehensive recovery, anti-aging benefits, and improved sleep quality.

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that functions as a telomerase activator, playing a crucial role in regulating the cell cycle and combating age-related decline. By stimulating telomerase, Epithalon helps to elongate telomeres, the protective caps at the ends of chromosomes, thereby protecting DNA from damage and cellular senescence. This protocol is designed for providers seeking to offer patients an evidence-based approach to promoting longevity, improving cellular health, and mitigating the physiological effects of aging.

GHK-Cu is a naturally occurring copper peptide with extensive regenerative and protective properties. This protocol is designed to leverage GHK-Cu's ability to upregulate collagen and elastin production, accelerate wound healing, and reduce inflammation, making it a powerful treatment for skin rejuvenation and hair loss.

This protocol leverages the synergistic effects of GHK-Cu and Epithalon for comprehensive anti-aging and skin rejuvenation. GHK-Cu, a copper peptide, stimulates collagen and elastin production, improves skin firmness, and accelerates wound healing for a revitalized appearance. Epithalon works at the cellular level by activating telomerase to protect DNA and regulate circadian rhythms, combating the root causes of aging.

This protocol uses Gonadorelin, a synthetic analog of gonadotropin-releasing hormone (GnRH), to stimulate the pituitary gland's production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is prescribed for female infertility caused by hypothalamic amenorrhea to induce ovulation. It is also used in males on testosterone replacement therapy (TRT) to prevent testicular atrophy and maintain endogenous testosterone production.

This protocol utilizes IGF-1 LR3, a long-acting analog of insulin-like growth factor-1, to stimulate muscle growth (hyperplasia and hypertrophy) and accelerate recovery. It is prescribed for patients seeking enhanced athletic performance, improved body composition, and mitigation of age-related muscle loss.

This protocol utilizes Kisspeptin, a potent upstream regulator of the reproductive axis, to stimulate the release of Gonadotropin-Releasing Hormone (GnRH). It is prescribed for patients with suspected hypothalamic-pituitary-gonadal (HPG) axis dysfunction to diagnose and treat conditions like hypogonadotropic hypogonadism and functional hypothalamic amenorrhea.

MOTS-c is a mitochondrial-derived peptide that plays a crucial role in regulating metabolic homeostasis and cellular energy. This protocol is intended for patients looking to improve insulin sensitivity, optimize metabolic function, and increase overall vitality and exercise performance, particularly in the context of age-related metabolic decline.

This protocol is designed to counteract the age-related decline in Nicotinamide Adenine Dinucleotide (NAD+), a critical coenzyme for cellular energy metabolism and DNA repair. By restoring NAD+ levels, this therapy aims to enhance mitochondrial function, boost cellular energy production, and activate sirtuins, which are key proteins involved in longevity and cellular health. It is prescribed for patients seeking to improve vitality, cognitive function, and overall wellness as part of a comprehensive anti-aging strategy.

This advanced protocol combines three synergistic peptides—Pinealon, PE-22-28, and Selank—to offer comprehensive cognitive enhancement, neuroprotection, and anxiolytic benefits. It is designed for patients seeking to improve memory, focus, and mental clarity while simultaneously reducing anxiety and improving mood. The combination of these peptides provides a multi-faceted approach to brain health and cognitive performance.

PT-141 (Bremelanotide) is a synthetic peptide and melanocortin receptor agonist used to treat sexual dysfunction in both men and women. It is particularly effective for hypoactive sexual desire disorder (HSDD) by acting on the central nervous system to increase sexual desire and arousal. This protocol is designed for patients seeking to improve libido and overall sexual satisfaction.

This protocol combines the nootropic effects of Semax with the anxiolytic properties of Selank to offer a comprehensive approach to cognitive enhancement and mood regulation. Semax is known to improve memory, focus, and learning, while Selank helps to reduce anxiety and stress without causing sedation. The synergistic action of this combination makes it a valuable tool for providers treating patients with cognitive decline, brain fog, or anxiety-related conditions.

This protocol uses Sermorelin, a growth hormone-releasing hormone (GHRH) analog, to stimulate the patient's own pituitary gland to produce and release growth hormone. It offers a more natural and pulsatile approach to optimizing GH levels compared to direct administration of human growth hormone (HGH), which can suppress natural production. Providers would prescribe this to address age-related growth hormone decline and its associated symptoms.

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue that stimulates the pituitary gland to secrete growth hormone. This protocol is designed to reduce visceral adipose tissue (VAT) in patients with lipodystrophy, particularly in the context of HIV, but it is also used off-label for general visceral fat reduction. By increasing endogenous growth hormone and IGF-1 levels, it promotes lipolysis and can improve body composition and metabolic parameters.

This protocol combines Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone (GH) secretagogue. Together, they synergistically enhance the body's natural production and release of GH to support fat loss, particularly visceral adipose tissue, and promote lean muscle mass. This dual-action approach provides a more potent and physiologic stimulation of the GH axis compared to single-agent therapies.

Thymosin Alpha-1 is a synthetic peptide that is a potent modulator of the immune system. This protocol is designed to enhance immune surveillance and response, particularly in immunocompromised individuals or those with chronic infections, by stimulating T-cell production and maturation. It is used to restore immune function and help the body defend against various pathogens and malignancies.

5-Amino-1MQ is a novel small molecule that inhibits the enzyme Nicotinamide N-methyltransferase (NNMT), leading to increased NAD+ levels and enhanced cellular metabolism. Available as both injectable and oral capsule formulations for flexible dosing.

This advanced protocol combines SLU-PP-332, a novel exercise mimetic, with BAM15, a potent mitochondrial uncoupler. SLU-PP-332 activates metabolic pathways normally stimulated by exercise, while BAM15 enhances cellular energy expenditure. This synergistic action promotes significant fat loss, improves insulin sensitivity, and enhances overall metabolic function, making it a powerful therapeutic for metabolic syndrome and obesity.

SLU-PP 332 is a novel, orally active ERR agonist that functions as an exercise mimetic. This protocol is designed for providers looking to offer a cutting-edge therapy for patients struggling with metabolic syndrome, obesity, or who wish to enhance their response to exercise. By activating the ERRα, β, and γ receptors, SLU-PP 332 stimulates metabolic pathways typically activated by aerobic exercise, leading to increased fatty acid oxidation and improved energy expenditure.

This protocol leverages Glutathione, the body's master antioxidant, to protect cells from oxidative damage, support natural detoxification processes, and enhance immune function. It is prescribed for patients seeking to improve their overall wellness, skin health, and resilience against environmental stressors.

The Lipo-B Metabolic Support Protocol is a series of lipotropic injections containing a blend of Methionine, Inositol, Choline (MIC), and Vitamin B12. These ingredients work synergistically to enhance fat metabolism, prevent the accumulation of fats in the liver, and increase energy levels. This protocol is designed for providers to complement a patient's existing weight management plan, including diet and exercise.